Demographic profile (n = 46) | |
 Age (years) (Median: IQR) | 60.5 (45.75–72) |
 Gender: male/female (%, n) | 69.6/30.4 (32/14) |
 Patients with known sleep disorder (%, n) | 28.3 (13) |
 Weight (kg) (Median: IQR) | 89 (74.75–97.25) |
 Height (cm) (Median: IQR) | 175.5 (170–181) |
 BMI (kg/m2) (Median: IQR) | 28.1 (23.83–30.9) |
Clinical acuity (Median: IQR) | |
 APACHEII score | 20.5 (14–25.75) |
 Relative mortality risk | 36.8 (18.65–55.97) |
 SOFA score | 13 (9–16) |
RASS score (%, n) | |
 Lightly sedated (− 2) | 0 |
 Drowsy (− 1) | 26.1 (12) |
 Calm and co-operative (0) | 50 (23) |
 Restless (+ 1) | 17.4 (8) |
 Agitated (+ 2) | 4.3 (2) |
 Very agitated (+ 3) | 2.2 (1) |
 Confusion assessment method: positive (%, n) | 2.2 (1) |
Admission classification (%, n) | |
 ICU/HDU | 56.5/43.5 (26/20) |
Reason for admission (%, n) | |
 Bacterial pneumonia | 13 (6) |
 Cardiovascular | 19.6 (9) |
 Respiratory failure | 15.2(7) |
 Multi-trauma | 10.9 (5) |
 Sepsis | 15.2 (7) |
 Cardiac arrest | 4.3 (2) |
 General surgical | 13 (6) |
 Other | 8.8 (4) |
Respiratory support (%, n) | |
 Nil | 8.7 (4) |
 Oxygen therapy | 23.9 (11) |
 Hi Flow Nasal Prongs | 32.6 (15) |
 Non-invasive ventilation | 4.3 (2) |
 Mechanical ventilation | 30.4 (14) |
 CRRT (%, n) | 15.2 (7) |
 IABP | 6.5 (3) |
Pharmacological agents (%, n) | |
 Benzodiazepine | 10.9 (5) |
 Opioids | 52.2 (24) |
 Melatonin | 10.9 (5) |
 Length of ICU stay: hours (Median: IQR) | 152.5 (75–330.25) |